NYSE: DLB

Dolby Laboratories (DLB) Stock Analysis & Forecast

Nov 13 close

$63.61−0.98 (−1.5%)

Gekko Brief

Nov 9 close

Dolby Laboratories closed at $64.79 on 9 November 2026, -0.1% on the day. The price sits above both the 50-day ($60.77) and 200-day ($59.34) moving averages, inside a 52-week range of $48.26 to $69.95. The GekkoIndex reads 46.8, in the Neutral zone, down 4.6 points over five sessions. Gekko Fair Value is $72.43, so the price is 10.5% below it.

The next earnings report is due on 17 November 2026, 2 days away (after close). Over the last 8 reports the company beat the earnings estimate 7 times, with an average move of 7.5% across the report. Seasonally, the next 20 trading days from this point averaged +4% over the last 5 years, rising in 4 of them.

2 firms rate the stock: 2 buy, 0 hold and 0 sell, with a consensus target of $79.00. A typical daily move is about 2.6%, and a typical 20-day move about 4.2%. On the swing-trade checklist, 3 items read supportive and 1 reads as a headwind (earnings risk).

A plain summary of the figures as of the Nov 9, 2026 close.

Dolby Laboratories price vs fair value

$71.23$63.61Nov ’25May ’26Nov ’26
Close $63.61200-day averageGekko Fair Value $71.23

Dolby Laboratories quick facts

Market cap
$5.96B
P/E ratio
27.5
Forward P/E
14.1
EPS, TTM
$2.35
Revenue, TTM
$1.35B
Profit margin
16.7%
Dividend yield
2.23%
Beta
0.78
Volume
1.26M avg 638,910
1-year return
−4.8%
Typical daily move
±2.7%
Typical 20-day move
±4.2%
50-day average
$60.99
200-day average
$59.38
Next earnings
Nov 17 after close
Shares outstanding
59.42M
52-week range
$48.26$69.95

Dolby Laboratories swing-trade checklist

Dolby Laboratories scores 3 supportive, 1 mixed and 1 headwind across the 5 checklist items with data.

Six things swing traders check before a 20-day hold, read from the latest data.

3 supportive1 mixed1 headwind

  • Trendsupportive

    Above 50 and 200-day

    Close $63.61 is above the 50-day ($60.99) and 200-day ($59.38) averages, and the 50-day is above the 200-day.

    See the chart
  • GekkoIndexmixed

    51.7, Neutral

    Reading 51.7 is in the Neutral zone.

    See the GekkoIndex
  • Fair valuesupportive

    10.7% below

    Price is 10.7% below Gekko Fair Value (more than 5% below).

    See fair value
  • Smart moneyno data

    No data

    No insider, Congress or unusual options activity in the window.

    See smart money
  • Earnings riskheadwind

    Reports in 2 days

    Reports on Nov 17, 2026, 2 days away — inside a typical 20-trading-day hold.

    See earnings
  • Seasonalitysupportive

    +3.4% on average

    From this point in the calendar, the next 20 trading days averaged +3.4% over 5 years, rising in 4 of them.

    See seasonality

A description of current data, not a recommendation. How this page works

Dolby Laboratories stock chart and price history

Dolby Laboratories closed at $63.61 on Nov 13, 2026, −4.8% over the past year, inside a 52-week range of $48.26 to $69.95.

Close50-day average200-day averageVolume
Dolby Laboratories share price, past year, with 50-day and 200-day moving averages and volume$50$55$60$70$75DecJan 2026FebMarAprMayJunJulAugSepOctNov63.61

Use the left and right arrow keys to read daily values.

Performance Breakdown

1 month
+4.6%
3 months
+3.7%
6 months
+17.3%
1 year
−4.8%
The full DLB chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open DLB in Gekko

Follow Dolby Laboratories through every session

Put DLB on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.

Track DLB in GekkoFree for 7 days. No credit card required.

About Dolby Laboratories

Dolby Laboratories creates audio and imaging technologies used to improve sound and picture quality across entertainment and communication systems, spanning movie theaters, television broadcasts, streaming platforms, mobile devices and home entertainment setups. It is widely recognized for its audio and video coding formats, including AAC, AVC, Dolby AC-4, Dolby Atmos, Dolby Digital and its variants, Dolby TrueHD, HEVC, and imaging and voice technologies such as Dolby Vision and Dolby Voice, which together shape how sound and visuals are delivered on many types of playback equipment.

The company generates revenue partly by licensing these technologies to other manufacturers and media platforms, while also designing and building physical products such as cinema servers, processors, amplifiers, loudspeakers and video conferencing equipment. It provides supporting services for theatrical and television production, covering exhibition, broadcast operations and home entertainment needs. Its customer base includes film studios, content creators, post-production houses, cinema operators, broadcasters and video game developers, reached both directly and through a worldwide network of dealers and distributors.

Dolby Laboratories was founded in 1965 and is headquartered in San Francisco, California. Its shares are listed on the NYSE under the ticker DLB.

Listed
NYSE
Sector
Technology services
Industry
Packaged software
Website
dolby.com

Dolby Laboratories GekkoIndex: the smart money zone

Dolby Laboratories’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 51.7, in the Neutral zone, up 6 points over five sessions.

010051.7Neutral

Up 6 points over five sessions.

Reading for Nov 13, 2026

What followed past readings in each zone

ZoneReadings5 days10 days20 days50 days
Buying38+0.7%+2.0%+2.6%+0.9%
Accumulation311+0.1%+0.3%+1.4%−0.4%
Neutral (current zone)340−0.4%−1.2%−2.9%−3.8%
Distribution12+0.4%+1.7%−0.6%−0.7%
Selling1Too few readings yet

Average DLB share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +0.9% over 20 days. Past behaviour doesn’t guarantee future results.

Neutral zone: No clear directional signal. About the five zones →

See every daily GekkoIndex reading plotted over the DLB price, zone by zone.Track DLB in Gekko

Is Dolby Laboratories stock overvalued? Gekko Fair Value

Dolby Laboratories trades 10.7% below Gekko Fair Value of $71.23, so the shares are undervalued on Gekko’s estimate.

Gekko’s own estimate of what Dolby Laboratories shares are worth, recalculated every trading day.

$71.23

Gekko Fair Value, Nov 14, 2026

10.7% Undervalued

At the end of Aug 2026 the price was 15.0% below the estimate.

Gekko Fair ValueShare price, month end
$71$64Aug 2026SepOctNov 2026

How Gekko Fair Value works →

Gekko Fair Value on every chart, with the gap to price updating daily.Open DLB in Gekko

Dolby Laboratories insider and Congress trading

No open-market insider purchases were filed for Dolby Laboratories, and no Congress trades were disclosed, in the last 90 days.

Plus buybacks, unusual options and fund positions, each dated to when it became public.

Insider buying last 90 days

No open-market insider purchases were filed for DLB in the last 90 days.

From Form 4 filings, dated to when each was filed.

Every DLB insider filing, plotted on the chart in Gekko.Open DLB in Gekko

Congress trades last 90 days

No trades in DLB were disclosed by members of Congress in the last 90 days.

From congressional disclosures, which report amounts as ranges.

Congress disclosures for DLB, plotted on the chart in Gekko.Open DLB in Gekko

Buybacks

Dolby Laboratories has been buying back its own shares.

Latest authorization
$350.0M, Jul 30, 2026
Bought back, quarter ended Jun 26, 2026
$65.89M
As a share of market cap
1.11%
Trailing four quarters
$269.2M

From company filings.

Dolby Laboratories earnings: next date and track record

Dolby Laboratories reports on Nov 17, 2026, after the close (2 days away), and beat the EPS estimate in 7 of its last 8 reports.

7 of 8reports beat the EPS estimate
±7.5%average move across the report
5 of 8reports followed by a gain

Share-price move across each report

+14.9%Nov ’24+8.3%Jan ’25−2.5%May ’25−7.4%Jul ’25+0.7%Nov ’25+4.9%Jan ’26−9.2%Apr ’26+11.9%Jul ’26

Last earnings call, Jul 30, 2026 AI summary

What they said
Dolby reported Q3 FY26 revenue of $305 million and non-GAAP EPS of $0.69, which were within prior guidance. Management highlighted strong momentum entering Q4 driven by growth in Dolby Atmos, Dolby Vision, imaging patents, and the Video Distribution Program (VDP), noting major new VDP licensees including Meta and Alibaba. The company is expanding beyond device licensing into content partnerships with a target of 10% of revenue from content partners by FY28. They generated ~$167 million in operating cash flow, repurchased $65 million of stock this quarter and increased the buyback authorization by $350 million; the dividend was raised 9% to $0.36. A small $4 million restructuring charge was recorded. Management expects strong sequential growth in Q4 and provided detailed Q4 guidance. Management discussed product progress (Dolby Vision 2.0, OptiView low-latency streaming and targeted ads), automotive adoption, and potential headwinds from memory cost inflation affecting mobile and PC end markets.
Guidance
Q4 FY26 revenue: $362M - $392M (licensing $335M - $365M). Non-GAAP gross margin ~90%. Non-GAAP operating expenses $195M - $205M. Non-GAAP EPS $1.13 - $1.28. Company narrowed full-year range while keeping midpoint unchanged and expects strong sequential growth in Q4 driven by pipeline momentum.
Risks flagged
Management cited macroeconomic events, supply chain issues, inflation, changes in consumer spending, geopolitical instability, and memory price increases (which particularly affect mobile and PC BOMs) as risks that could impact future performance. They also noted potential quarterly volatility from timing of minimum volume commitments and true-ups. A $4M restructuring charge reflects organizational alignment risk.
ReportedEPSSurpriseRevenueSurpriseMove
Jul 30, 2026$0.43
est $0.40
+7.5%$305.0M
est $312.0M
−2.2%+11.9%
Apr 30, 2026$0.00
est $1.34
−100.0%$395.6M
est $385.8M
+2.5%−9.2%
Jan 29, 2026$1.06
est $0.99
+6.7%$346.7M
est $341.3M
+1.6%+4.9%
Nov 18, 2025$0.99
est $0.70
+41.6%$307.0M
est $305.8M
+0.4%+0.7%
Jul 31, 2025$0.78
est $0.71
+9.2%$315.5M
est $305.8M
+3.2%−7.4%
May 1, 2025$1.34
est $1.27
+5.5%$369.6M
est $305.2M
+21.1%−2.5%
Jan 29, 2025$1.14
est $0.98
+16.3%$357.0M
est $383.8M
−7.0%+8.3%
Nov 19, 2024$0.81
est $0.70
+15.7%$304.8M
est $307.9M
−1.0%+14.9%

“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.

Dolby Laboratories stock forecast and analyst price targets

Analysts’ average 12-month price target for Dolby Laboratories is $79.00, +24.2% from the last close, from 2 firms rating the stock in the last 90 days.

$79.00consensus 12-month target, +24.2% from the last close
Buy2
Hold0
Sell0

Each firm’s latest rating in the last 90 days: 2 firms.

Latest analyst actions

DateFirmRatingTargetvs price
Oct 19BarringtonBuy, reiterated$90+41.5%
Aug 27William BlairBuy, maintained——
−2.9%average 20-day move after past Neutral readings
+3.4%average move over the next 20 trading days in the last 5 years
±2.7%typical daily move, from the 14-day average range

Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.

Dolby Laboratories seasonality: the next 20 trading days

Over the next 20 trading days from Nov 14, Dolby Laboratories averaged +3.4% across the last 5 years, rising in 4 of them.

Next 20 trading days, by year

+2.3%2021+4.3%2022−0.5%2023+8.2%2024+1.6%2025

Average move and hit rate

WindowAverageYears higher
Next 5 trading days+1.2%2 of 5
Next 10 trading days+0.5%3 of 5
Next 15 trading days+2.8%3 of 5
Next 20 trading days+3.4%4 of 5
Next 30 trading days+2.0%2 of 5

For scale, DLB’s typical 20-trading-day move in either direction is about 4.2%.

Dolby Laboratories market cap and key statistics

Dolby Laboratories’s market cap is $5.96B, with a P/E ratio of 27.5 and revenue of $1.35B over the last twelve months.

Valuation

Market cap
$5.96B
P/E ratio
27.5
Forward P/E
14.1
EPS, TTM
$2.35
Gekko Fair Value
$71.23

Trading

Volume
1.26M
Avg volume, 20 days
638,910
52-week high
$69.95
52-week low
$48.26
Shares outstanding
59.42M

Financials

Revenue, TTM
$1.35B
Profit margin
16.7%
Return on equity
8.8%
Quarterly earnings growth, YoY
−37.5%

Risk and income

Beta
0.78
Typical daily move
±2.7%
Typical 20-day move
±4.2%
Dividend yield
2.23%

Dolby Laboratories stock news this week

1 headline about Dolby Laboratories from the past week, newest first, each linking to the publisher.

Dolby Laboratories peers

Dolby Laboratories’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.

StockTodayGekkoIndex zonevs Fair Value
MSFTMicrosoft+0.8%Neutral10.6% above
PLTRPalantir Technologies−2.2%Accumulation8.2% below
ORCLOracle−1.7%Neutral27.9% below
PANWPalo Alto Networks−2.5%Accumulation0.6% above
CRWDCrowdStrike−4.0%Accumulation0.9% above
CRMSalesforce−1.0%Accumulation12.1% below

A peer links to its own page where one exists.

In the Buying zone today

Reporting earnings this week

Popular on Gekko

More stocks in Packaged software

Dolby Laboratories stock FAQ

What is Dolby Laboratories’s market cap?

Dolby Laboratories’s market cap is $5.96B at the Nov 13, 2026 close of $63.61, with 59.42M shares outstanding. The shares trade on a P/E ratio of 27.5.

What is the Dolby Laboratories stock forecast?

The consensus analyst 12-month price target for Dolby Laboratories is $79.00, +24.2% from the last close. Of the 2 firms that rated the stock in the last 90 days, 2 rate it a buy, 0 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.

Is Dolby Laboratories stock overvalued or undervalued?

On Gekko’s estimate Dolby Laboratories is undervalued: the Nov 13, 2026 close of $63.61 is 10.7% below Gekko Fair Value of $71.23. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.

When does Dolby Laboratories report earnings next?

Dolby Laboratories is expected to report on Nov 17, 2026, after the market closes (2 days away). Analysts expect earnings of $1.19 per share on revenue of $372.8M. Dolby Laboratories beat the earnings estimate in 7 of its last 8 reports, moving 7.5% on average across the report.

What is Dolby Laboratories’s 52-week high and low?

Dolby Laboratories’s 52-week high is $69.95 and its 52-week low is $48.26; it closed at $63.61 on Nov 13, 2026, −4.8% over the past year. Over the last five years the shares peaked at $96.85 on Jan 3, 2022.

Is Dolby Laboratories stock a buy right now?

Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 5 items with data read as supportive (trend, fair value and seasonality), 1 as mixed (gekkoindex) and 1 as a headwind (earnings risk). The checklist is a description of current data, not a recommendation.

How this page works

During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →

See Dolby Laboratories the way Gekko members do

Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.

Join 1,475 other traders using Gekko

Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.